Acute Fulminant Myocarditis in a Pediatric Patient With COVID-19 Infection

Diego Lara1,2, Thomas Young1,2, Kamill Del Toro1

  • 1Ochsner Hospital for Children, New Orleans, Louisiana; and.

Pediatrics
|August 5, 2020
PubMed

Insights

Coronavirus disease 2019 (COVID-19) can cause severe heart inflammation (myocarditis) in children. This case report details a rare instance of fulminant myocarditis in an adolescent with COVID-19.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Cardiovascular Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) predominantly affects the lungs.
  • Cardiac injury, including myocarditis, is observed in adults with COVID-19.
  • Pediatric COVID-19 cases and associated cardiac conditions are infrequently reported.

Purpose of the Study:

  • To report a rare case of severe cardiac disease in an adolescent with COVID-19.
  • To highlight the potential for COVID-19 to cause fulminant myocarditis in pediatric patients.
  • To contribute to the understanding of COVID-19's impact on the pediatric cardiovascular system.

Main Methods:

  • Case presentation of an adolescent female diagnosed with COVID-19.
  • Clinical assessment including electrocardiography and cardiac biomarkers.
  • Echocardiographic evaluation of cardiac function and structure.

Main Results:

  • The patient presented with fulminant myocarditis and complete heart block.
  • Elevated troponin I levels indicated significant myocardial injury.
  • Severely depressed systolic function was documented.
  • COVID-19 infection was confirmed as the likely cause.

Conclusions:

  • COVID-19 can lead to severe myocarditis and cardiac dysfunction in adolescents.
  • This case underscores the importance of considering cardiac involvement in pediatric COVID-19.
  • Further research is needed to understand the long-term cardiovascular sequelae of COVID-19 in children.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
97
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
157
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
235
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
136
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
637
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
513